CT Assessment of BMI in Endometrial Cancer Patients
September 15, 2021 updated by: Royal Cornwall Hospitals Trust
Computed Tomography Assessment of Body Fat Distribution in Endometrial Cancer Patients
This study is a retrospective study to investigate the association between body fat distribution and sarcopenia on CT-scan and oncological outcomes in endometrial cancer patients
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
302
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Cornwall
-
Truro, Cornwall, United Kingdom, TR1 3LJ
- Royal Cornwall Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 99 years (Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
Endometrial cancer patients
Description
Inclusion Criteria:
- Confirmed diagnosis of endometrial cancer
- Age: 18 years or older
- Abdominal CT-scan as part of pre-operative or post-operative staging work-up (<1 month after surgery)
Exclusion Criteria:
- Women with concurrent cancer
- Women with unknown body mass index
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Investigation of Patients with High BMI and Survival Rates
Time Frame: 10 years
|
To investigate the association between body fat distribution and sarcopenia on CT-scan and survival in endometrial cancer patients
|
10 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2019
Primary Completion (Actual)
March 1, 2021
Study Completion (Actual)
March 31, 2021
Study Registration Dates
First Submitted
April 17, 2019
First Submitted That Met QC Criteria
May 22, 2019
First Posted (Actual)
May 23, 2019
Study Record Updates
Last Update Posted (Actual)
September 16, 2021
Last Update Submitted That Met QC Criteria
September 15, 2021
Last Verified
September 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2019.RCHT.39
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.